Skip to content

Straumann® BLC and TLC Implants SLActive Roxolid TL (REF 035.7608S)Recalls & reported problems

Institut Straumann AG · TLC SP Implant, Ø 4.5mm WT, SLActive® 8mm, Roxolid® · Class 2 · Implant

All models of Straumann BLC and TLC Implants (153)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann TLC dental implant is placed into bone. Its 254 reports mostly describe the implant failing to bond with the bone, with some mentioning fibrosis (scar tissue), pain and infection. There were no deaths and 254 injuries, and reports rose to 166 in the last 12 months from 76 in the 12 months before. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
260
Deaths reported
0
Injuries reported
260
Recalls naming it
0

Summary

The FDA's MAUDE database contains 260 adverse event reports that list this exact device (DI 07630031766762), received between Apr 25, 2024 and Sep 28, 2026 — classified as 260 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (210 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 2 reportsMay 2024: 2 reportsJun 2024: 0 reportsJul 2024: 2 reportsAug 2024: 1 reportsSep 2024: 2 reportsOct 2024: 3 reportsNov 2024: 2 reportsDec 2024: 1 reportsJan 2025: 2 reportsFeb 2025: 0 reportsMar 2025: 10 reportsApr 2025: 4 reportsMay 2025: 0 reportsJun 2025: 26 reportsJul 2025: 12 reportsAug 2025: 6 reportsSep 2025: 5 reportsOct 2025: 8 reportsNov 2025: 10 reportsDec 2025: 7 reportsJan 2026: 10 reportsFeb 2026: 16 reportsMar 2026: 17 reportsApr 2026: 17 reportsMay 2026: 23 reportsJun 2026: 19 reportsJul 2026: 23 reportsAug 2026: 18 reportsSep 2026: 12 reportsOct 2026: 0 reports20242025202626
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate210
  • Loss of Osseointegration26
  • Adverse Event Without Identified Device or Use Problem19
  • Difficult to Insert5

Patient problems

  • No Clinical Signs, Symptoms or Conditions123
  • Fibrosis108
  • Pain51
  • Unspecified Infection27
  • Hemorrhage/Blood Loss/Bleeding12
  • Hyperresponsive to stimuli12
  • Inflammation11
  • Abscess5

Recent adverse event reports

The 25 most recent of 260 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Unspecified Infection

    MAUDE report 50920560 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Pain; Unspecified Infection

    MAUDE report 50919837 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50919397 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Pain

    MAUDE report 50826331 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50806912 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50759647 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Hyperresponsive to stimuli

    MAUDE report 50759601 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Unspecified Infection

    MAUDE report 50758956 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738240 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain

    MAUDE report 50654619 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654086 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain

    MAUDE report 50653095 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50416742 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 14. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III, fair oral hygiene and previous bone augmentation. The device was forwarded to the manufacturer. At the event the patient experienced: Pain, Mobility and Increased Sensitivity. No further patient complications were reported.

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain

    MAUDE report 50416281 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50414283 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hyperresponsive to stimuli; Pain

    MAUDE report 50413607 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 3. On (b)(6) 2026, non-osseointegration was verified. Patient presented with previous bone augmentation. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility and Inflammation. No further patient complications were reported.

    Patient problems: Fibrosis; Inflammation

    MAUDE report 50283572 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50281880 ↗
  • InjuryAug 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 3. On (b)(6) 2026, non-osseointegration was verified. Patient presented with previous bone augmentation. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility and Inflammation. No further patient complications were reported.

    Patient problems: Fibrosis; Inflammation

    MAUDE report 50281227 ↗
  • InjuryAug 14, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50259112 ↗
  • InjuryAug 14, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50259089 ↗
  • InjuryAug 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50258900 ↗
  • InjuryAug 13, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 37. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50239683 ↗
  • InjuryAug 13, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Pain; Unspecified Infection

    MAUDE report 50239676 ↗
  • InjuryAug 10, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Pain and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Pain

    MAUDE report 50199867 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page